Abstract
Abstract. Cardiometabolic diseases are a major global health problem affecting millions of people worldwide. Addressing this problem requires a multifaceted approach that includes lifestyle changes, medical interventions, and public health strategies to reduce the prevalence and impact of these diseases. A comprehensive examination is a key element of prevention and early detection of cardiometabolic diseases. Thanks to careful anamnesis and diagnosis, we can identify risks in time and develop individual treatment and prevention programs that significantly improve the prognosis and patients´ quality of life. Aim. To develop a diagnostic system for determining the risks of cardiovascular, metabolic and renal diseases. Materials. The analysis was conducted in the PubMed Central database using the keywords «cardiometabolic diseases», «diagnosis and prevention of cardiometabolic diseases» for the period from 2019 to 2023. Results. There was developed the IDIS2GO diagnostic system to automate the collection and evaluation of medical and diagnostic data based on the latest recommendations of world professional associations, using artificial intelligence algorithms and training own neural networks. IDIS2GO consists of three parts: the first part is the patient's history (questions included in the examination are aimed at identifying risk factors and potential health problems); the second part – diagnostic procedures (based on the answers to the above questions, users can perform the following diagnostic procedures for a more detailed assessment of the patient's state of health); the third part is risk assessment scales (cardiovascular disease, lipids, diabetes and emergencies). Thus, IDIS-2GO is a new diagnostic system designed to optimize the medical examination process. It is a portable, integrated solution that includes advanced diagnostic tools and a powerful software platform for real-time health monitoring and clinical decision support. IDIS2GO combines cardiovascular risk scoring algorithms (SCORE2 and SCORE2-OP) and diabetes screening for a comprehensive risk assessment. The IDIS2GO system helps to collect all these data in a single examination file. The data are automatically entered into the cloud storage and can be transferred to any information system, ensuring their availability to the doctor at a convenient time. The doctor can interpret the data, evaluate them and give the necessary recommendations.
References
Budreviciute A, Damiati S, Sabir DK, Onder K, Schuller-Goetzburg P, Plakys G, et al. Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Front Public Health. 2020 Nov 26;8:574111. doi: 10.3389/fpubh.2020.574111.
Dominguez LJ, Di Bella G, Veronese N, Barbagallo M. Impact of mediterranean diet on chronic non-communicable diseases and longevity. Nutrients. 2021 Jun 12;13(6):2028. doi: 10.3390/nu13062028.
Guan B, Wang A, Xu H. Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis. Cardiovasc Diabetol. 2023 Aug 10;22(1):207. doi: 10.1186/s12933-023-01927-z.
Park MJ, Choi KM. Association between variability of metabolic risk factors and cardiometabolic outcomes. Diabetes Metab J. 2022 Jan;46(1):49-62. doi: 10.4093/dmj.2021.0316.
Small AM, Yutzey KE, Binstadt BA, Voigts Key K, Bouatia-Naji N, Milan D, et al. Unraveling the mechanisms of valvular heart disease to identify medical therapy targets: a scientific statement from the American Heart Association. Circulation. 2024 Jun 17. doi: 10.1161/CIR.0000000000001254.
Tahir UA, Gerszten RE. Molecular biomarkers for cardiometabolic disease: risk assessment in young individuals. Circ Res. 2023 Jun 9;132(12):1663-73. doi: 10.1161/CIRCRESAHA.123.322000.
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-337. doi: 10.1093/eurheartj/ehab484. Erratum in: Eur Heart J. 2022 Nov 7;43(42):4468. doi: 10.1093/eurheartj/ehac458.
